newsfilter
← Latest News
GlobeNewswire·

Autolus Therapeutics to Report Third Quarter 2026 Financial Results and Host Conference Call on November 10, 2026

LONDON and GAITHERSBURG, Md., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ:AUTL), a commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed